Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/102067
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNicholls, S.-
dc.contributor.authorRuotolo, G.-
dc.contributor.authorBrewer, H.-
dc.contributor.authorWang, M.-
dc.contributor.authorLiu, L.-
dc.contributor.authorWilley, M.-
dc.contributor.authorDeeg, M.-
dc.contributor.authorKrueger, K.-
dc.contributor.authorNissen, S.-
dc.date.issued2016-
dc.identifier.citationJournal of Clinical Lipidology, 2016; 10(3):519-527-
dc.identifier.issn1933-2874-
dc.identifier.issn1876-4789-
dc.identifier.urihttp://hdl.handle.net/2440/102067-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityStephen J. Nicholls, Giacomo Ruotolo, H. Bryan Brewer, Ming-Dauh Wang, Liping Liu, Mark B. Willey, Mark A. Deeg, Kathryn A. Krueger, Steven E. Nissen-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2016 National Lipid Association. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.jacl.2015.11.014-
dc.subjectCETP inhibitor; Evacetrapib; Lipoprotein(a); LDL particle; Small LDL; Hypercholesterolemia-
dc.titleEvacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients-
dc.typeJournal article-
dc.identifier.doi10.1016/j.jacl.2015.11.014-
pubs.publication-statusPublished-
dc.identifier.orcidNicholls, S. [0000-0002-9668-4368]-
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.